Explorador de Cadeias de Suprimentos

Pfizer Inc.

PFE · Grande ($10B+)

Moderna, Inc.

MRNA · Médio ($2B–$10B)

Eli Lilly and Company

LLY · Mega ($200B+)

Novo Nordisk

NVO · Mega ($200B+)

Regeneron Pharmaceuticals

REGN · Grande ($10B+)

BioNTech SE

BNTX · Médio ($2B–$10B)

Vertex Pharmaceuticals

VRTX · Grande ($10B+)

BioMarin Pharmaceutical

BMRN · Médio ($2B–$10B)

Exact Sciences Corporation

EXAS · Médio ($2B–$10B)

Intellia Therapeutics

NTLA · Pequeno (<$2B)

AbbVie Inc.

ABBV · Mega ($200B+)

Amgen Inc.

AMGN · Grande ($10B+)

Gilead Sciences, Inc.

GILD · Grande ($10B+)

Alnylam Pharmaceuticals, Inc.

ALNY · Médio ($2B–$10B)

CRISPR Therapeutics AG

CRSP · Pequeno (<$2B)

Ionis Pharmaceuticals, Inc.

IONS · Médio ($2B–$10B)

Merck & Co.

MRK · Mega ($200B+)

AstraZeneca

AZN · Mega ($200B+)

Sanofi

SNY · Mega ($200B+)

GSK plc

GSK · Grande ($10B+)

Viatris Inc.

VTRS · Médio ($2B–$10B)

Organon & Co.

OGN · Pequeno (<$2B)

Biogen Inc.

BIIB · Grande ($10B+)

Incyte Corporation

INCY · Médio ($2B–$10B)

Novartis AG

NVS · Mega ($200B+)